Institutional Ownership Eledon Pharmaceuticals, Inc. (ELDN)
This table provides information about the institutional ownership of Eledon Pharmaceuticals, Inc. (ELDN). We have compiled data on the 34 institutions that hold shares in the stock, with a total of 18.4 Million shares, which have been reported (via 13F filing form) to have a value of $71.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Pathstone Holdings, LLC
Englewood, NJ |
Nov 07, 2024 Q3 2024 |
13,029
shares
|
$52,246
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Pathstone Family Office, LLC
Englewood, NJ |
Nov 08, 2023 Q3 2023 |
13,029
shares
|
$52,246
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Clarity Capital Partners LLC
Newport Beach, CA |
Oct 30, 2024 Q3 2024 |
11,500
shares
|
$46,115
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Two Sigma Securities, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
11,027
shares
|
$44,218
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
6,816
shares
|
$27,332
0.0% of portfolio
|
Q3 2024
Reduced 0.03%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Nov 14, 2024 Q3 2024 |
1,532
shares
|
$6,143
0.0% of portfolio
|
Q3 2024
Reduced 90.97%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
97
shares
|
$388
0.0% of portfolio
|
Q3 2024
Added 6.59%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
4
shares
|
$16
0.0% of portfolio
|
Q3 2024
Reduced 99.99%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|